Medicines coverage through health insurance programs can be a scalable and sustainable means to improve access to, affordability and use of medicines. Evidence-based medicines policy decision making is required to achieve maximum benefits at affordable costs. This inaugural course for policy makers, analysts, actuaries, and others involved in making medicines policy decisions in health and insurance systems was organized by the WHO Collaborating Center in Pharmaceutical Policy, Boston, USA; Ateneo de Manila University; and the Philippine Health Insurance Corporation, Manila, Philippines, at the Ateneo Professional Schools, Ateneo de Manila University, Rockwell Center, Makati City, Philippines, from September 23 trhough 29, 2007.
The highly interactive course enhanced participants' skills to identify problems in medicines access and use, and to design, implement, and evaluate medicines benefit policies in heath systems. It consisted of small and large group case discussions and hands-on analyses of health insurance program data. During the course, participants focused on medicines policy issues relevant to their systems, and developed post-course plans to design and implement policy interventions to improve key health outcomes.
The Department of Ambulatory Care and Prevention (DACP) at Harvard Medical School and Harvard Pilgrim Health Care; the German Organization for Technical Collaboration (GTZ); the UK Department for International Development (DfID); the World Health Organization, Geneva (WHO); and the World Health Organization Western Pacific Regional Office (WPRO).